HK1245127A1 - 治療腦疾病的方法和組合物 - Google Patents
治療腦疾病的方法和組合物Info
- Publication number
- HK1245127A1 HK1245127A1 HK18104750.2A HK18104750A HK1245127A1 HK 1245127 A1 HK1245127 A1 HK 1245127A1 HK 18104750 A HK18104750 A HK 18104750A HK 1245127 A1 HK1245127 A1 HK 1245127A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- compositions
- methods
- brain diseases
- treating brain
- treating
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/46—Hydrolases (3)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
- A61K48/005—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy characterised by an aspect of the 'active' part of the composition delivered, i.e. the nucleic acid delivered
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0085—Brain, e.g. brain implants; Spinal cord
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y306/00—Hydrolases acting on acid anhydrides (3.6)
- C12Y306/05—Hydrolases acting on acid anhydrides (3.6) acting on GTP; involved in cellular and subcellular movement (3.6.5)
- C12Y306/05002—Small monomeric GTPase (3.6.5.2)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
- C12N2750/00011—Details
- C12N2750/14011—Parvoviridae
- C12N2750/14111—Dependovirus, e.g. adenoassociated viruses
- C12N2750/14141—Use of virus, viral particle or viral elements as a vector
- C12N2750/14143—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201462098085P | 2014-12-30 | 2014-12-30 | |
| PCT/US2015/068034 WO2016109649A1 (en) | 2014-12-30 | 2015-12-30 | Methods and compositions for treating brain diseases |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| HK1245127A1 true HK1245127A1 (zh) | 2018-08-24 |
Family
ID=56285031
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HK18104750.2A HK1245127A1 (zh) | 2014-12-30 | 2018-04-11 | 治療腦疾病的方法和組合物 |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US11612641B2 (zh) |
| EP (1) | EP3240577B1 (zh) |
| JP (1) | JP6782701B2 (zh) |
| KR (1) | KR102618947B1 (zh) |
| CN (1) | CN107405414A (zh) |
| AU (1) | AU2015374043B2 (zh) |
| BR (1) | BR112017013674A2 (zh) |
| CA (1) | CA2971687A1 (zh) |
| ES (1) | ES2962439T3 (zh) |
| HK (1) | HK1245127A1 (zh) |
| SG (1) | SG11201704829QA (zh) |
| WO (1) | WO2016109649A1 (zh) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3218484A4 (en) | 2014-11-14 | 2018-05-30 | Voyager Therapeutics, Inc. | Compositions and methods of treating amyotrophic lateral sclerosis (als) |
| SG11201704829QA (en) | 2014-12-30 | 2017-07-28 | Univ Iowa Res Found | Methods and compositions for treating brain diseases |
| WO2017201258A1 (en) | 2016-05-18 | 2017-11-23 | Voyager Therapeutics, Inc. | Compositions and methods of treating huntington's disease |
| EP3458588A4 (en) | 2016-05-18 | 2020-01-15 | Voyager Therapeutics, Inc. | MODULATING POLYNUCLEOTIDES |
| CL2016003282A1 (es) * | 2016-12-21 | 2017-08-18 | Univ Chile | Virus aav/igf2, método de tratamiento genético y su uso en enfermedades relacionadas con mal plegamiento de proteínas tal como la enfermedad de huntington |
| WO2018132791A1 (en) * | 2017-01-16 | 2018-07-19 | The Regents Of The University Of California | Treatment of neurodegenerative conditions by disruption of rhes |
| WO2018204803A1 (en) | 2017-05-05 | 2018-11-08 | Voyager Therapeutics, Inc. | Compositions and methods of treating huntington's disease |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20050255086A1 (en) | 2002-08-05 | 2005-11-17 | Davidson Beverly L | Nucleic acid silencing of Huntington's Disease gene |
| US20050009112A1 (en) | 2003-03-07 | 2005-01-13 | Fred Hutchinson Cancer Research Center, Office Of Technology Transfer | Methods for identifying Rheb effectors as lead compounds for drug development for diabetes and diseases associated with abnormal cell growth |
| US20100087474A1 (en) | 2005-04-27 | 2010-04-08 | University Of Florida | Materials and methods for enhanced degradation of mutant proteins associated with human disease |
| KR101286870B1 (ko) * | 2009-11-30 | 2013-07-16 | (주)아모레퍼시픽 | 황기 추출물을 포함하는 대사 촉진 조성물 |
| WO2013061305A1 (en) | 2011-10-28 | 2013-05-02 | Novartis Ag | Novel purine derivatives and their use in the treatment of disease |
| US9511036B2 (en) | 2011-11-01 | 2016-12-06 | Children's Medical Center Corporation | Co-activation of mTOR and STAT3 pathways to promote neuronal survival and regeneration |
| US20140377285A1 (en) | 2011-11-08 | 2014-12-25 | Intellikine, Llc | Treatment regimens using multiple pharmaceutical agents |
| WO2013116691A1 (en) | 2012-02-02 | 2013-08-08 | The Washington University | Methods for improving muscle strength |
| KR101626526B1 (ko) | 2014-10-30 | 2016-06-02 | 경북대학교 산학협력단 | ｈＲｈｅｂ를 유효성분으로 포함하는 허혈성 뇌질환의 예방 또는 치료용 조성물 |
| SG11201704829QA (en) | 2014-12-30 | 2017-07-28 | Univ Iowa Res Found | Methods and compositions for treating brain diseases |
-
2015
- 2015-12-30 SG SG11201704829QA patent/SG11201704829QA/en unknown
- 2015-12-30 EP EP15876243.5A patent/EP3240577B1/en active Active
- 2015-12-30 WO PCT/US2015/068034 patent/WO2016109649A1/en active Application Filing
- 2015-12-30 CN CN201580077153.9A patent/CN107405414A/zh active Pending
- 2015-12-30 JP JP2017534822A patent/JP6782701B2/ja active Active
- 2015-12-30 US US15/540,746 patent/US11612641B2/en active Active
- 2015-12-30 KR KR1020177020915A patent/KR102618947B1/ko active IP Right Grant
- 2015-12-30 CA CA2971687A patent/CA2971687A1/en active Pending
- 2015-12-30 AU AU2015374043A patent/AU2015374043B2/en active Active
- 2015-12-30 ES ES15876243T patent/ES2962439T3/es active Active
- 2015-12-30 BR BR112017013674A patent/BR112017013674A2/pt not_active Application Discontinuation
-
2018
- 2018-04-11 HK HK18104750.2A patent/HK1245127A1/zh unknown
Also Published As
| Publication number | Publication date |
|---|---|
| KR20170098931A (ko) | 2017-08-30 |
| EP3240577A4 (en) | 2018-07-25 |
| JP6782701B2 (ja) | 2020-11-11 |
| KR102618947B1 (ko) | 2023-12-27 |
| CA2971687A1 (en) | 2016-07-07 |
| ES2962439T3 (es) | 2024-03-19 |
| BR112017013674A2 (pt) | 2018-02-06 |
| EP3240577B1 (en) | 2023-07-05 |
| AU2015374043B2 (en) | 2021-05-13 |
| SG11201704829QA (en) | 2017-07-28 |
| CN107405414A (zh) | 2017-11-28 |
| US20180000907A1 (en) | 2018-01-04 |
| JP2018502112A (ja) | 2018-01-25 |
| AU2015374043A1 (en) | 2017-07-13 |
| WO2016109649A1 (en) | 2016-07-07 |
| US11612641B2 (en) | 2023-03-28 |
| EP3240577A1 (en) | 2017-11-08 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL283561B (en) | Methods for treating eye diseases | |
| HK1232141A1 (zh) | 用於治療亨廷頓病的方法和組合物 | |
| ZA201705673B (en) | Methods for treating skin | |
| IL252159B (en) | Methods and formulations for the treatment of diseases of the blood vessels of the eye | |
| HK1225305A1 (zh) | 治療腦疾病的方法和組合物 | |
| IL246791A0 (en) | Compositions and methods for treating eye diseases | |
| HK1246179A1 (zh) | 治療視網膜疾病的方法 | |
| HK1254432A1 (zh) | 用於治療纖維性疾病的方法和組合物 | |
| EP3139928A4 (en) | Anordrin compositions and methods for treating diseases | |
| HK1245127A1 (zh) | 治療腦疾病的方法和組合物 | |
| EP3110446A4 (en) | Methods and compositions for treating siglec-8 associated diseases | |
| HK1258994A1 (zh) | 用於疾病治療的方法 | |
| ZA201606673B (en) | Compositions and methods for treating neurodegenerative diseases | |
| EP3164132A4 (en) | Methods and compositions for treating diseases and conditions | |
| HK1246206A1 (zh) | 用於治療青光眼的組合物和方法 | |
| AP2017009724A0 (en) | Methods and compositions for treating hiv-related disorders | |
| IL252904A0 (en) | Methods and factors for treating diseases | |
| HK1244782A1 (zh) | 用於治療疾病和病癥的組合物和方法 | |
| HK1243937A1 (zh) | 治療疾病的方法 | |
| GB201521083D0 (en) | Compositions for treatment and methods thereof | |
| SG10201400823PA (en) | Therapeutic methods and compositions for treating diabetes |